Tolga Tanguler

Tolga Tanguler is a declared insider of Alnylam Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Between 1 February 2022 and 4 March 2026, the trades on record add up to 37 filings.

Sales make up the whole of the open-market record (20 sales, €2.8M). Other entries cover 12 share grants and 5 option exercises. Since January 2026: no purchases and 2 sales on the market.

Most recently, on 6 March 2026, the filings show an open-market sale worth €29k in Alnylam Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.